Skip to content

Drug interactions

Dasatinib + Givinostat

Severity: Major

Dasatinib and Givinostat: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Givinostat and dasatinib can each prolong the QT interval, so combined use may increase the risk of ventricular arrhythmia. Givinostat labeling advises caution with other QT-prolonging drugs.

What this interaction means in plain words

Dasatinib and Givinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Dasatinib belongs to Oncology; Givinostat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Additive pharmacodynamic QT prolongation.

What to do

Avoid the combination if possible. If it is unavoidable, obtain ECGs at initiation and during treatment, and withhold givinostat if the QTc exceeds 500 ms or rises more than 60 ms from baseline.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Givinostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Givinostat?

MediHelp rates the interaction as major. Dasatinib and Givinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Givinostat and dasatinib can each prolong the QT interval, so combined use may increase the risk of ventricular arrhythmia. Givinostat labeling advises caution with other QT-prolonging drugs.

How serious is the interaction between Dasatinib and Givinostat?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If it is unavoidable, obtain ECGs at initiation and during treatment, and withhold givinostat if the QTc exceeds 500 ms or rises more than 60 ms from baseline.

What other medicines interact with Dasatinib?

MediHelp also lists interactions of Dasatinib with, for example, Saquinavir, Thioridazine, Adagrasib. The full list is on the Dasatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in